Beneficial Ownership Report · SCHEDULE 13G
BioStem Technologies, Inc.
BSEMNASDAQEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13G
primary_doc.xml
Subject company
- Company
- Biostem Technologies, Inc.
- Company CIK
- 0001658678
- Street
- 2836 Center Port Circle
- City
- Pompano Beach
- State / country code
- FL
- Postal code
- 33604
Statement details
- Security class
- Common Stock
- Event date
- 10/31/2026
- Rule designation
- Rule 13d-1(b)
Reporting person 1
- Name
- The PNC Financial Services Group, Inc.
- Citizenship / organization
- PA
- Reporting person type
- HC
- Aggregate amount owned
- 1,941,390
- Percent of class
- 10.40
- Sole voting power
- 1,941,390
- Shared voting power
- 0
- Sole dispositive power
- 793,847
- Shared dispositive power
- 0
- Aggregate excludes certain shares
- N
Item 1
Issuer
Biostem Technologies, Inc.
Principal executive office address
2836 Center Port Circle, Pompano Beach, Florida 33604
Item 2
Citizenship
Pennsylvania
Filing person
The PNC Financial Services Group, Inc.
Principal business or residence address
300 Fifth Avenue, Pittsburgh, PA 15222-2401
Item 3
Not applicable indication
N
Type of filing person
HC
Item 4
Percent of class
10.40
Amount beneficially owned
1,941,390
Sole voting power
1,941,390
Shared voting power
0
Sole dispositive power
793,847
Shared dispositive power
0
Item 5
Not applicable indication
Y
Item 6
Not applicable indication
Y
Item 7
Not applicable indication
N
Subsidiaries
PNC Bank, National Association - BK PNC Ohio Trust Company - BK Of the total shares reported herein, 1,691,390 are held in accounts at PNC Bank, National Association in a fiduciary capacity for clients. Of the total shares reported herein, 250,000 are held in accounts at PNC Ohio Trust Company in a fiduciary capacity for clients.
Item 8
Not applicable indication
Y
Item 9
Not applicable indication
Y
Item 10
Not applicable indication
N
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Signature 1
- Reporting person
- The PNC Financial Services Group, Inc.
- Signed
- Gregory H. Kozich
- Title
- Senior Vice President & Controller
- Date
- 11/05/2026
Company context
BioStem Technologies, Inc. is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain®, CryoTek® and SteriTek® processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.